Researchers at UT Southwestern announced successful results of a clinical trial for a commonly prescribed weight-loss drug called liraglutide. In adults who are overweight or have obesity combined with high cardiovascular ...
Aug 4, 2021
0
420
Results from the multi-cohort Phase I/II ARROW clinical trial, conducted by The University of Texas MD Anderson Cancer Center researchers, showed that a once-daily dose of pralsetinib, a highly selective RET inhibitor, was ...
Jun 10, 2021
0
1
Researchers investigating the impact of COVID-19 on the NHS in the UK reviewed the health records of 14 million people between March and December 2020 and found that the diagnosis of type 2 diabetes was missed or delayed ...
May 18, 2021
0
9
(HealthDay)—The risk for severe COVID-19 leading to hospital admission and death is increased at a body mass index (BMI) of more than 23 kg/m2, according to a study published online April 28 in The Lancet Diabetes & Endocrinology.
May 4, 2021
0
13
The first large study to report the effect of bodyweight on risk of worse outcomes from COVID-19 across the full range of body-mass index (BMI) is published today in The Lancet Diabetes & Endocrinology journal.
May 3, 2021
0
0
A three-year intervention designed to reduce weight gain in overweight and obese Latino children generated improvements in body mass index and many other health measures during the trial's initial two years, according to ...
Apr 30, 2021
0
6
Studies have shown that supplementary vitamin D seems to provide a certain degree of protection against respiratory infections. A new study involving researchers from Karolinska Institutet has now made the most comprehensive ...
Mar 31, 2021
0
253
Translational research led by scientists at La Jolla Institute for Immunology (LJI) has resulted in a promising combination therapeutic candidate for adults with recent-onset type 1 diabetes.
Mar 9, 2021
0
46
Cancer is the leading cause of death among people with diabetes in England.
Feb 4, 2021
0
17
A QIMR Berghofer-led randomized controlled trial of vitamin D supplements has found they do not protect most people from developing colds, flus and other acute respiratory infections.
Jan 14, 2021
2
167
